HSPA8 and Parkinson disease: In line with this, the treatment with the selective inhibitor of HDAC6 Tubastatin A reduces both astrocyte reactivity and neuron degeneration induced by α-synuclein in a rat PD model, increasing Lamp2a and Hsc70 expression and partially inducing α-synuclein acetylation (Francelle et al., 2020).